Tag: automation in biopharma industry market share

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Automation In Biopharma Industry Market Expected To Reach $3.15 Billion By 2030 At 7.7% CAGR

The biopharmaceutical sector’s automation market has witnessed robust expansion, projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate of 7.1%. This upward trajectory during the historical period is underpinned by several key factors, including the escalating complexity associated with biologic drug manufacturing, a growing need for scalable biopharmaceutical production capabilities, the early embracement of laboratory automation solutions, the proliferation of contract manufacturing services, and significant advancements in process control technologies.

The biopharmaceutical sector’s automation market is poised for significant expansion, projecting a valuation of $3.16 billion by 2030, reflecting a compound annual growth rate of 7.7%. This anticipated surge is fueled by escalating investments in intelligent biomanufacturing infrastructure, the wider embrace of continuous production methods, advancements in personalized biologic manufacturing, a heightened need for regulatory adherence in automation, and a concentrated effort to refine manufacturing output. Key developments shaping this period include the increasing deployment of automated production systems, the greater incorporation of digital twin methodologies, the expanded utilization of automated quality assurance processes, comprehensive automation across bioprocessing, and a stronger emphasis on manufacturing guided by data analytics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

#Automation In Biopharma Industry Market Growth Drivers And Industry Catalysts

The expanding utilization of robotic systems within the pharmaceutical production sector is anticipated to be a significant catalyst for the advancement of the automation in the biopharma industry market. These sophisticated automated systems and machinery are instrumental in executing diverse functions throughout the creation and packaging of medicinal goods. Their application spans numerous facets of pharmaceutical manufacturing, including but not limited to, secondary packaging operations, internal logistics management, laboratory process automation, pick-and-place activities, the streamlining of pharmacy workflows, and the development of personalized medicines. Such widespread deployment leads to substantial improvements in productivity, elevates precision levels, minimizes contamination risks, and bolsters the safety of the workforce. Illustrating this trend, September 2024 data from the International Federation of Robotics, a renowned German non-profit entity, indicated a robust 9% surge in industrial robot installations across Europe’s manufacturing landscape, achieving an all-time peak of 92,393 units. Notably, a substantial 80% of these installations, amounting to 73,534 units, were situated within the European Union, reflecting a 2% year-over-year increase. Consequently, the escalating integration of robots in pharmaceutical manufacturing is poised to propel the expansion of the automation in biopharma industry market.

Automation In Biopharma Industry Market Segment Breakdown: Which Categories Generate The Most Revenue?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

#Automation In Biopharma Industry Market Trends Influencing Long-Term Demand

Within the biopharmaceutical sector, leading enterprises are actively driving automation initiatives, specifically targeting the enhancement of technological capabilities like robotic platforms designed for cell-therapy production. These advanced systems are engineered to achieve large-scale, highly efficient, and accuracy-improved manufacturing of sophisticated therapies. A typical robotic cell-therapy manufacturing setup integrates autonomous mobile units, sterile liquid management tools, automated pipe joining mechanisms, and digitized workflow oversight, creating a completely sealed and adaptable environment. This stands in stark contrast to conventional manual bioprocessing methods, which are considerably labor-intensive and utilize open containment strategies. As an illustration, in May of 2023, Cellular Origins, a UK entity specializing in life sciences automation, introduced Constellation, an adaptable robotic framework intended for the creation of cutting-edge therapies. This platform features integrated autonomous mobile robots, aseptic liquid conveyance systems, and modular processing stations, facilitating smooth incorporation into established bioprocessing operations. It achieves a remarkable 30-fold improvement in spatial utilization, necessitates 16 times less human effort, and slashes manufacturing expenses by 51%, all while providing comprehensive digital connectivity for quality assurance and remote oversight.

Automation In Biopharma Industry Market Key Players And Strategic Industry Positioning

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Automation In Biopharma Industry Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Automation In Biopharma Industry Market Expected To Reach $3.15 Billion By 2030 At 7.7% CAGR

The biopharmaceutical sector’s automation market has witnessed robust expansion, projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate of 7.1%. This upward trajectory during the historical period is underpinned by several key factors, including the escalating complexity associated with biologic drug manufacturing, a growing need for scalable biopharmaceutical production capabilities, the early embracement of laboratory automation solutions, the proliferation of contract manufacturing services, and significant advancements in process control technologies.

The biopharmaceutical sector’s automation market is poised for significant expansion, projecting a valuation of $3.16 billion by 2030, reflecting a compound annual growth rate of 7.7%. This anticipated surge is fueled by escalating investments in intelligent biomanufacturing infrastructure, the wider embrace of continuous production methods, advancements in personalized biologic manufacturing, a heightened need for regulatory adherence in automation, and a concentrated effort to refine manufacturing output. Key developments shaping this period include the increasing deployment of automated production systems, the greater incorporation of digital twin methodologies, the expanded utilization of automated quality assurance processes, comprehensive automation across bioprocessing, and a stronger emphasis on manufacturing guided by data analytics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

#Automation In Biopharma Industry Market Growth Drivers And Industry Catalysts

The expanding utilization of robotic systems within the pharmaceutical production sector is anticipated to be a significant catalyst for the advancement of the automation in the biopharma industry market. These sophisticated automated systems and machinery are instrumental in executing diverse functions throughout the creation and packaging of medicinal goods. Their application spans numerous facets of pharmaceutical manufacturing, including but not limited to, secondary packaging operations, internal logistics management, laboratory process automation, pick-and-place activities, the streamlining of pharmacy workflows, and the development of personalized medicines. Such widespread deployment leads to substantial improvements in productivity, elevates precision levels, minimizes contamination risks, and bolsters the safety of the workforce. Illustrating this trend, September 2024 data from the International Federation of Robotics, a renowned German non-profit entity, indicated a robust 9% surge in industrial robot installations across Europe’s manufacturing landscape, achieving an all-time peak of 92,393 units. Notably, a substantial 80% of these installations, amounting to 73,534 units, were situated within the European Union, reflecting a 2% year-over-year increase. Consequently, the escalating integration of robots in pharmaceutical manufacturing is poised to propel the expansion of the automation in biopharma industry market.

Automation In Biopharma Industry Market Segment Breakdown: Which Categories Generate The Most Revenue?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

#Automation In Biopharma Industry Market Trends Influencing Long-Term Demand

Within the biopharmaceutical sector, leading enterprises are actively driving automation initiatives, specifically targeting the enhancement of technological capabilities like robotic platforms designed for cell-therapy production. These advanced systems are engineered to achieve large-scale, highly efficient, and accuracy-improved manufacturing of sophisticated therapies. A typical robotic cell-therapy manufacturing setup integrates autonomous mobile units, sterile liquid management tools, automated pipe joining mechanisms, and digitized workflow oversight, creating a completely sealed and adaptable environment. This stands in stark contrast to conventional manual bioprocessing methods, which are considerably labor-intensive and utilize open containment strategies. As an illustration, in May of 2023, Cellular Origins, a UK entity specializing in life sciences automation, introduced Constellation, an adaptable robotic framework intended for the creation of cutting-edge therapies. This platform features integrated autonomous mobile robots, aseptic liquid conveyance systems, and modular processing stations, facilitating smooth incorporation into established bioprocessing operations. It achieves a remarkable 30-fold improvement in spatial utilization, necessitates 16 times less human effort, and slashes manufacturing expenses by 51%, all while providing comprehensive digital connectivity for quality assurance and remote oversight.

Automation In Biopharma Industry Market Key Players And Strategic Industry Positioning

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Automation In Biopharma Industry Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Automation In Biopharma Industry Market Expected To Reach $3.15 Billion By 2030 At 7.7% CAGR

The biopharmaceutical sector’s automation market has witnessed robust expansion, projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate of 7.1%. This upward trajectory during the historical period is underpinned by several key factors, including the escalating complexity associated with biologic drug manufacturing, a growing need for scalable biopharmaceutical production capabilities, the early embracement of laboratory automation solutions, the proliferation of contract manufacturing services, and significant advancements in process control technologies.

The biopharmaceutical sector’s automation market is poised for significant expansion, projecting a valuation of $3.16 billion by 2030, reflecting a compound annual growth rate of 7.7%. This anticipated surge is fueled by escalating investments in intelligent biomanufacturing infrastructure, the wider embrace of continuous production methods, advancements in personalized biologic manufacturing, a heightened need for regulatory adherence in automation, and a concentrated effort to refine manufacturing output. Key developments shaping this period include the increasing deployment of automated production systems, the greater incorporation of digital twin methodologies, the expanded utilization of automated quality assurance processes, comprehensive automation across bioprocessing, and a stronger emphasis on manufacturing guided by data analytics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

#Automation In Biopharma Industry Market Growth Drivers And Industry Catalysts

The expanding utilization of robotic systems within the pharmaceutical production sector is anticipated to be a significant catalyst for the advancement of the automation in the biopharma industry market. These sophisticated automated systems and machinery are instrumental in executing diverse functions throughout the creation and packaging of medicinal goods. Their application spans numerous facets of pharmaceutical manufacturing, including but not limited to, secondary packaging operations, internal logistics management, laboratory process automation, pick-and-place activities, the streamlining of pharmacy workflows, and the development of personalized medicines. Such widespread deployment leads to substantial improvements in productivity, elevates precision levels, minimizes contamination risks, and bolsters the safety of the workforce. Illustrating this trend, September 2024 data from the International Federation of Robotics, a renowned German non-profit entity, indicated a robust 9% surge in industrial robot installations across Europe’s manufacturing landscape, achieving an all-time peak of 92,393 units. Notably, a substantial 80% of these installations, amounting to 73,534 units, were situated within the European Union, reflecting a 2% year-over-year increase. Consequently, the escalating integration of robots in pharmaceutical manufacturing is poised to propel the expansion of the automation in biopharma industry market.

Automation In Biopharma Industry Market Segment Breakdown: Which Categories Generate The Most Revenue?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

#Automation In Biopharma Industry Market Trends Influencing Long-Term Demand

Within the biopharmaceutical sector, leading enterprises are actively driving automation initiatives, specifically targeting the enhancement of technological capabilities like robotic platforms designed for cell-therapy production. These advanced systems are engineered to achieve large-scale, highly efficient, and accuracy-improved manufacturing of sophisticated therapies. A typical robotic cell-therapy manufacturing setup integrates autonomous mobile units, sterile liquid management tools, automated pipe joining mechanisms, and digitized workflow oversight, creating a completely sealed and adaptable environment. This stands in stark contrast to conventional manual bioprocessing methods, which are considerably labor-intensive and utilize open containment strategies. As an illustration, in May of 2023, Cellular Origins, a UK entity specializing in life sciences automation, introduced Constellation, an adaptable robotic framework intended for the creation of cutting-edge therapies. This platform features integrated autonomous mobile robots, aseptic liquid conveyance systems, and modular processing stations, facilitating smooth incorporation into established bioprocessing operations. It achieves a remarkable 30-fold improvement in spatial utilization, necessitates 16 times less human effort, and slashes manufacturing expenses by 51%, all while providing comprehensive digital connectivity for quality assurance and remote oversight.

Automation In Biopharma Industry Market Key Players And Strategic Industry Positioning

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Automation In Biopharma Industry Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Automation In Biopharma Industry Market By 2030?

Strong growth has been observed in the automation in biopharma industry market size in recent years. This market is projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to this historical expansion include the escalating complexity of biologic drug production, rising demand for scalable biopharma manufacturing, early adoption of laboratory automation, the expansion of contract manufacturing services, and advancements in process control technologies.

The automation in biopharma industry market size is projected to undergo robust expansion over the next few years. It is forecast to reach $3.16 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. The growth anticipated during this forecast period can be attributed to several factors, including increasing investments in smart biomanufacturing facilities, the growing adoption of continuous manufacturing processes, the expansion of personalized biologics production, a rising demand for regulatory-compliant automation, and an increasing focus on optimizing manufacturing efficiency. Key trends for the forecast period encompass the increasing adoption of robotic manufacturing platforms, the rising integration of digital twin technologies, the growing use of automated quality control systems, the expansion of end-to-end bioprocess automation, and an enhanced focus on data-driven manufacturing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Influential Factors Are Boosting The Automation In Biopharma Industry Market Demand?

The expanding integration of robots within pharmaceutical production is projected to boost the expansion of the automation in biopharma industry market. These robots, utilized in pharmaceutical manufacturing, are sophisticated automated systems and machinery designed to execute diverse functions in the fabrication and packaging of pharmaceutical goods. Their widespread application in pharmaceutical production encompasses areas like secondary packaging, intralogistics, laboratory automation, pick and place operations, the automation of pharmacy processes, and personalized medicine, leading to benefits such as increased productivity, improved precision, a lower risk of contamination, and enhanced safety for workers. As an illustration, in September 2024, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that industrial robot installations across the manufacturing sector in Europe rose by 9%, reaching an unprecedented total of 92,393 units. Among these, 80% were deployed within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the growing integration of robots in pharmaceutical production will propel the expansion of the automation in biopharma industry market.

Which Segment-Based Categories Are Covered In The Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Which Trends Are Supporting The Evolution Of The Automation In Biopharma Industry Market?

Significant companies are driving automation in the biopharma industry market, concentrating on creating technological advancements such as robotic platforms for cell-therapy manufacturing, designed to enable scalable, efficient, and less error-prone production of advanced therapies. Such a robotic cell-therapy manufacturing platform integrates mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a completely closed and modular system. This innovation supersedes conventional manual bioprocessing, which heavily depends on labor and open setups. For example, in May 2023, Cellular Origins, a UK-based life sciences automation company, introduced Constellation, a configurable robotic platform tailored for advanced therapy manufacture. This particular platform incorporates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, facilitating smooth integration into existing bioprocessing workflows. It significantly enhances space efficiency by 30 times, decreases labor requirements by 16-fold, and lowers production costs by 51%, concurrently providing comprehensive digital interconnection for quality control and remote monitoring.

Who Are The Firms Contributing To The Automation In Biopharma Industry Market Ecosystem?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Holds The Largest Share In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Automation In Biopharma Industry Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Bioprocess Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Pharmacy Automation Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Automation In Biopharma Industry Market By 2030?

Strong growth has been observed in the automation in biopharma industry market size in recent years. This market is projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to this historical expansion include the escalating complexity of biologic drug production, rising demand for scalable biopharma manufacturing, early adoption of laboratory automation, the expansion of contract manufacturing services, and advancements in process control technologies.

The automation in biopharma industry market size is projected to undergo robust expansion over the next few years. It is forecast to reach $3.16 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. The growth anticipated during this forecast period can be attributed to several factors, including increasing investments in smart biomanufacturing facilities, the growing adoption of continuous manufacturing processes, the expansion of personalized biologics production, a rising demand for regulatory-compliant automation, and an increasing focus on optimizing manufacturing efficiency. Key trends for the forecast period encompass the increasing adoption of robotic manufacturing platforms, the rising integration of digital twin technologies, the growing use of automated quality control systems, the expansion of end-to-end bioprocess automation, and an enhanced focus on data-driven manufacturing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Influential Factors Are Boosting The Automation In Biopharma Industry Market Demand?

The expanding integration of robots within pharmaceutical production is projected to boost the expansion of the automation in biopharma industry market. These robots, utilized in pharmaceutical manufacturing, are sophisticated automated systems and machinery designed to execute diverse functions in the fabrication and packaging of pharmaceutical goods. Their widespread application in pharmaceutical production encompasses areas like secondary packaging, intralogistics, laboratory automation, pick and place operations, the automation of pharmacy processes, and personalized medicine, leading to benefits such as increased productivity, improved precision, a lower risk of contamination, and enhanced safety for workers. As an illustration, in September 2024, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that industrial robot installations across the manufacturing sector in Europe rose by 9%, reaching an unprecedented total of 92,393 units. Among these, 80% were deployed within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the growing integration of robots in pharmaceutical production will propel the expansion of the automation in biopharma industry market.

Which Segment-Based Categories Are Covered In The Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Which Trends Are Supporting The Evolution Of The Automation In Biopharma Industry Market?

Significant companies are driving automation in the biopharma industry market, concentrating on creating technological advancements such as robotic platforms for cell-therapy manufacturing, designed to enable scalable, efficient, and less error-prone production of advanced therapies. Such a robotic cell-therapy manufacturing platform integrates mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a completely closed and modular system. This innovation supersedes conventional manual bioprocessing, which heavily depends on labor and open setups. For example, in May 2023, Cellular Origins, a UK-based life sciences automation company, introduced Constellation, a configurable robotic platform tailored for advanced therapy manufacture. This particular platform incorporates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, facilitating smooth integration into existing bioprocessing workflows. It significantly enhances space efficiency by 30 times, decreases labor requirements by 16-fold, and lowers production costs by 51%, concurrently providing comprehensive digital interconnection for quality control and remote monitoring.

Who Are The Firms Contributing To The Automation In Biopharma Industry Market Ecosystem?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Holds The Largest Share In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Automation In Biopharma Industry Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Bioprocess Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Pharmacy Automation Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cognitive Diagnostics Market During 2026–2030?

The cognitive diagnostics market size has experienced significant expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. The historical development can be linked to the rising prevalence of neurodegenerative disorders, heightened awareness of cognitive health, advancements in diagnostic imaging capabilities, increased adoption of standardized cognitive tests, and the expansion of neurology specialty clinics.

The cognitive diagnostics market is poised for substantial growth over the next few years. It is projected to expand to $17.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.7%. The expansion throughout the forecast period is fueled by escalating investments in digital diagnostics, an increasing need for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing incorporation of AI into clinical decision support, and a heightened emphasis on personalized cognitive care. Prominent trends anticipated in this period include the rising application of AI-based cognitive assessment instruments, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the widespread availability of remote cognitive testing solutions, and a reinforced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

What Leading Drivers Are Supporting The Cognitive Diagnostics Market Expansion?

The increasing occurrence of neurological conditions is anticipated to fuel expansion within the cognitive diagnostics market moving forward. These conditions, which impact the brain, spinal cord, and nervous system, hinder their proper functioning and manifest in symptoms like cognitive decline, motor impairment, and sensory issues. The surge in neurological disorders is largely attributable to a higher incidence of age-associated illnesses, including Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, alongside exposure to environmental toxins, stress, poor dietary habits, and inactive lifestyles, also contribute to their growing prevalence. Cognitive diagnostics play a crucial role in neurological diseases by evaluating, identifying, and tracking cognitive deficits, thereby assisting in the prompt diagnosis and management of conditions such as Alzheimer’s and Parkinson’s disease. For instance, in May 2024, a report from the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is a key factor driving the growth of the cognitive diagnostics market.

What Are The Key Segment Divisions In The Cognitive Diagnostics Market Segment Structure?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Emerging Trends Are Seen In The Cognitive Diagnostics Market?

Key companies operating in the cognitive diagnostics market are prioritizing real-time insights into cognitive health, propelled by technological advancements in diagnostic tools such as neuropsychological testing platforms, to heighten the accuracy, efficiency, and comprehensiveness of cognitive assessments. Neuropsychological testing platforms are specialized digital instruments created to evaluate cognitive functions through standardized tests, covering memory, attention, and problem-solving abilities. For instance, in April 2024, BrainCheck Inc., a US-based digital health company advancing cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its sophisticated tools for cognitive screening, assessment, and care planning. The platform, featuring Assess, Screen, and Plan, offers clinicians a contemporary solution to streamline cognitive health management with mobile, digital technology, ensuring precision and user-friendliness. This innovation aims to improve the efficiency and quality of care for patients and providers by delivering nuanced, evidence-based recommendations and thorough care planning.

Which Organizations Are Engaged In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Get The Full Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Region Dominates The Cognitive Diagnostics Market By Market Share?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cognitive Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Automation In Biopharma Industry Market Expected To Scale Between 2026 And 2030?

The market for automation in the biopharma industry has experienced substantial growth in recent years. It is forecast to increase from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The expansion observed during the historic period can be ascribed to several factors, including the increasing complexity of biologic drug production, a rising demand for scalable biopharma manufacturing solutions, the early adoption of laboratory automation, the broader reach of contract manufacturing services, and continuous advancements in process control technologies.

The automation in biopharma industry market is predicted to experience significant expansion in the coming years. Its valuation is expected to reach $3.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This projected increase is fueled by factors such as greater investments in intelligent biomanufacturing facilities, the rising adoption of continuous manufacturing, the widening scope of personalized biologics production, a growing demand for automation that adheres to regulations, and an intensified focus on optimizing manufacturing efficiency. Significant developments expected during this forecast period involve the increased deployment of robotic manufacturing platforms, the rising integration of digital twin technologies, a broader application of automated quality control systems, the expansion of comprehensive end-to-end bioprocess automation, and an enhanced emphasis on data-driven manufacturing processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Factors Are Contributing To The Growth Of The Automation In Biopharma Industry Market?

The expanding integration of robots into pharmaceutical production is anticipated to fuel the expansion of the automation in biopharma industry market. These robots are sophisticated automated systems and machinery designed to execute diverse operations in the creation and packaging of pharmaceutical goods. Their common applications within pharmaceutical manufacturing encompass areas like secondary packaging, intralogistics, laboratory automation, pick and place, streamlining pharmacy processes, and personalized medicine, which leads to benefits such as increased productivity, improved accuracy, lower contamination risks, and enhanced safety for workers. As an example, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that by September 2024, industrial robot installations within Europe’s manufacturing sector had climbed by 9%, setting a new record of 92,393 units. Of this total, the European Union accounted for 80% of installations, amounting to 73,534 units, which represented a 2% increase compared to the prior year. Consequently, the rising deployment of robots in pharmaceutical manufacturing is poised to accelerate the expansion of the automation in biopharma industry market.

What Are The Key Segment Divisions In The Automation In Biopharma Industry Market Segment Structure?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Trends Are Shaping The Future Of The Automation In Biopharma Industry Market?

Major companies are implementing automation within the biopharma industry market, with a focus on developing technological innovations such as robotic cell-therapy manufacturing platforms designed for the scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a fully closed and modular framework, replacing traditional manual bioprocessing that is highly labor-intensive and uses open systems. For instance, in May 2023, Cellular Origins, a UK-based life sciences automation company, launched Constellation, a configurable robotic platform intended for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless incorporation into existing bioprocessing workflows. It boosts space efficiency by 30 times, decreases labor requirements by 16-fold, and cuts production costs by 51%, while also offering full digital interconnection for quality control and remote monitoring.

Which Organizations Are Engaged In The Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Get The Full Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Is The Largest In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automation In Biopharma Industry Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Pharmacy Automation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Bioprocess Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Automation In Biopharma Industry Market Expected To Scale Between 2026 And 2030?

The market for automation in the biopharma industry has experienced substantial growth in recent years. It is forecast to increase from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The expansion observed during the historic period can be ascribed to several factors, including the increasing complexity of biologic drug production, a rising demand for scalable biopharma manufacturing solutions, the early adoption of laboratory automation, the broader reach of contract manufacturing services, and continuous advancements in process control technologies.

The automation in biopharma industry market is predicted to experience significant expansion in the coming years. Its valuation is expected to reach $3.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This projected increase is fueled by factors such as greater investments in intelligent biomanufacturing facilities, the rising adoption of continuous manufacturing, the widening scope of personalized biologics production, a growing demand for automation that adheres to regulations, and an intensified focus on optimizing manufacturing efficiency. Significant developments expected during this forecast period involve the increased deployment of robotic manufacturing platforms, the rising integration of digital twin technologies, a broader application of automated quality control systems, the expansion of comprehensive end-to-end bioprocess automation, and an enhanced emphasis on data-driven manufacturing processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Factors Are Contributing To The Growth Of The Automation In Biopharma Industry Market?

The expanding integration of robots into pharmaceutical production is anticipated to fuel the expansion of the automation in biopharma industry market. These robots are sophisticated automated systems and machinery designed to execute diverse operations in the creation and packaging of pharmaceutical goods. Their common applications within pharmaceutical manufacturing encompass areas like secondary packaging, intralogistics, laboratory automation, pick and place, streamlining pharmacy processes, and personalized medicine, which leads to benefits such as increased productivity, improved accuracy, lower contamination risks, and enhanced safety for workers. As an example, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that by September 2024, industrial robot installations within Europe’s manufacturing sector had climbed by 9%, setting a new record of 92,393 units. Of this total, the European Union accounted for 80% of installations, amounting to 73,534 units, which represented a 2% increase compared to the prior year. Consequently, the rising deployment of robots in pharmaceutical manufacturing is poised to accelerate the expansion of the automation in biopharma industry market.

What Are The Key Segment Divisions In The Automation In Biopharma Industry Market Segment Structure?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Trends Are Shaping The Future Of The Automation In Biopharma Industry Market?

Major companies are implementing automation within the biopharma industry market, with a focus on developing technological innovations such as robotic cell-therapy manufacturing platforms designed for the scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a fully closed and modular framework, replacing traditional manual bioprocessing that is highly labor-intensive and uses open systems. For instance, in May 2023, Cellular Origins, a UK-based life sciences automation company, launched Constellation, a configurable robotic platform intended for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless incorporation into existing bioprocessing workflows. It boosts space efficiency by 30 times, decreases labor requirements by 16-fold, and cuts production costs by 51%, while also offering full digital interconnection for quality control and remote monitoring.

Which Organizations Are Engaged In The Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Get The Full Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Is The Largest In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automation In Biopharma Industry Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Pharmacy Automation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Bioprocess Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Automation In Biopharma Industry Market At The End Of The 2026–2030 Forecast Period?

The market size for automation within the biopharma industry has experienced significant expansion in recent years. It is anticipated to increase from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical growth in this sector is attributable to factors such as the increasing complexity of biologic drug production, a rising demand for scalable biopharma manufacturing, the early adoption of laboratory automation, the expansion of contract manufacturing services, and advancements in process control technologies.

The market for automation within the biopharma industry is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $3.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. Several factors are driving this anticipated growth, including heightened investments in intelligent biomanufacturing plants, the increasing integration of continuous manufacturing processes, the broadening scope of personalized biologics production, a rising need for automation that adheres to regulatory standards, and a greater emphasis on enhancing manufacturing efficiency. Key trends expected during this period involve the wider implementation of robotic manufacturing platforms, the increasing incorporation of digital twin technologies, the expanded utilization of automated quality control systems, the spread of comprehensive end-to-end bioprocess automation, and an intensified focus on data-driven production methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Drivers Are Shaping The Future Growth Of The Automation In Biopharma Industry Market?

The growing integration of robots within pharmaceutical production is projected to boost the expansion of automation in the biopharmaceutical industry market. These robots are sophisticated automated systems and machinery designed to execute diverse operations in the creation and packaging of pharmaceutical goods. Their widespread use in pharmaceutical manufacturing covers several areas, including secondary packaging, intralogistics, laboratory automation, pick and place functions, the automation of pharmacy processes, and personalized medicine, leading to benefits such as increased productivity, better precision, a lower risk of contamination, and enhanced worker safety. An illustration of this trend is seen in September 2024, when industrial robot installations across the manufacturing sector in Europe saw a 9% rise, reaching an unprecedented 92,393 units, as reported by the International Federation of Robotics, a professional non-profit organization based in Germany. Out of this total, 80% were deployed within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the heightened implementation of robots in pharmaceutical production is set to fuel the expansion of automation within the biopharma industry market.

What Segment Types Make Up The Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Key Trends Are Influencing The Development Of The Automation In Biopharma Industry Market?

Leading companies in the biopharma industry market are actively implementing automation, with a specific focus on advancing technological innovations like robotic cell-therapy manufacturing platforms. These platforms are designed to enable the scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform typically combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control into a fully closed and modular system, thereby replacing traditional manual bioprocessing methods that rely heavily on labor and open systems. For example, in May 2023, Cellular Origins, a UK-based life sciences automation company, unveiled Constellation, a configurable robotic platform intended for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless incorporation into existing bioprocessing workflows. It boosts space efficiency by 30 times, reduces labor requirements by 16-fold, and cuts production costs by 51%, while simultaneously providing full digital interconnection for quality control and remote monitoring.

Who Are The Key Players Driving Competition In The Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Read the full automation in biopharma industry market report here:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Geographic Regions Are Influencing Demand In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automation In Biopharma Industry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Bioprocess Automation Global Market Report

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Pharmacy Automation Systems Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model